Papers
3
Total Citations
287
H-Index
2
About
Barbara Ercole is a urologic surgeon and clinical researcher whose work has made meaningful contributions to the evolving field of minimally invasive surgical oncology, with a particular focus on bladder cancer treatment. Her most significant contribution centers on the comparative evaluation of open versus robotic-assisted radical cystectomy (RARC), a technically demanding procedure used to treat muscle-invasive bladder cancer. Ercole's landmark 2012 pilot prospective randomized clinical trial — one of the first of its kind — directly addressed the limitations of prior retrospective studies by rigorously examining perioperative outcomes and oncologic efficacy in a controlled setting, ultimately accumulating 283 citations and establishing it as a foundational reference in urologic oncology literature. By helping to generate high-quality evidence around RARC's potential benefits — including reduced blood loss and lower transfusion rates — her research has informed surgical decision-making for clinicians worldwide. Her consistent focus on bladder cancer surgery across multiple peer-reviewed and conference publications underscores a commitment to translating clinical questions into actionable data. Ercole's work represents an important bridge between emerging robotic surgical technology and evidence-based oncologic practice, offering students and researchers a model of rigorous prospective trial design in surgical urology.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3